GAMMA Investing’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$124K Sell
2,628
-242
-8% -$12.4K ﹤0.01% 1646
2026
Q1
$170K Buy
2,870
+1,326
+86% +$86K 0.01% 1237
2025
Q4
$95.2K Buy
1,544
+361
+31% +$22.1K ﹤0.01% 1615
2025
Q3
$73.8K Sell
1,183
-1,197
-50% -$83.3K ﹤0.01% 1724
2025
Q2
$190K Buy
2,380
+501
+27% +$41.9K 0.01% 951
2025
Q1
$162K Buy
1,879
+496
+36% +$40.7K 0.01% 892
2024
Q4
$108K Buy
1,383
+220
+19% +$17.1K 0.01% 1058
2024
Q3
$83.9K Buy
1,163
+387
+50% +$27.4K 0.01% 1114
2024
Q2
$53.4K Buy
776
+263
+51% +$17.8K 0.01% 1146
2024
Q1
$37.2K Buy
513
+110
+27% +$7.36K 0.01% 1220
2023
Q4
$24.8K Buy
+403
New +$23.9K 0.01% 1350

Other funds holding PBH

GAMMA Investing's PBH Position: Q2 2026 in Review

GAMMA Investing reduced its Prestige Consumer Healthcare (PBH) stake by 8.4% in Q2 2026, selling an estimated $12.4K and leaving 2,628 shares worth $124K. The position accounts for ﹤0.01% of the portfolio, ranked #1646.

GAMMA Investing first reported a position in PBH in Q4 2023 and has held it in 11 quarters since. The position peaked at $190K in Q2 2025. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • GAMMA Investing held 2,628 shares of Prestige Consumer Healthcare worth $124K as of Q2 2026.
  • GAMMA Investing sold 242 Prestige Consumer Healthcare shares in Q2 2026, an estimated $12.4K.
  • Prestige Consumer Healthcare made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #1646 holding.
  • GAMMA Investing first reported a position in Prestige Consumer Healthcare in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Prestige Consumer Healthcare position peaked at $190K in Q2 2025.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.